{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:56:22Z","timestamp":1777395382722,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,5,3]]},"abstract":"<jats:p>Alzheimer\u2019s disease (AD) studies in cognitively normal (CN) older adults age\u226565 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A\u03b242\/A\u03b240, t-Tau\/A\u03b242, p-Tau\/A\u03b242) predicted changes in non-depressed mood states in CN older adults (N\u200a=\u200a248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.<\/jats:p>","DOI":"10.3233\/jad-215708","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:55:12Z","timestamp":1646402112000},"page":"141-148","source":"Crossref","is-referenced-by-count":15,"title":["Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"87","author":[{"given":"Ganesh M.","family":"Babulal","sequence":"first","affiliation":[{"name":"Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA"},{"name":"Institute of Public Health, Washington University in St. Louis, St. Louis, MO, USA"},{"name":"Department of Psychology, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa"},{"name":"Department of Clinical Research and Leadership, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Center for Clinical Studies, Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Roe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215708_ref1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/jnp.9.4.556","article-title":"Major and minor depression in Alzheimer\u2019s disease: Prevalence and impact","volume":"9","author":"Lyketsos","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-215708_ref2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10072-019-03840-4","article-title":"Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer\u2019s disease patients: A retrospective observational study","volume":"40","author":"Scaricamazza","year":"2019","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-215708_ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment","volume":"12","author":"Ismail","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215708_ref4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jagp.2018.05.002","article-title":"Depression and risk of Alzheimer\u2019s dementia: A longitudinal analysis to determine predictors of increased risk among older adults with depression","volume":"26","author":"Gallagher","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: A 28-year follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-215708_ref6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.3233\/JAD-215708_ref7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","article-title":"\u201cNoncognitive\u201d symptoms of early Alzheimer disease A longitudinal analysis","volume":"84","author":"Masters","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-215708_ref8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S1041610219001200","article-title":"Profile of mild behavioral impairment and factor structure of the mild behavioral impairment checklist in cognitively normal older adults","volume":"32","author":"Creese","year":"2020","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-215708_ref9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","article-title":"Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels","volume":"24","author":"Babulal","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-142940","article-title":"Depressive symptoms and biomarkers of Alzheimer\u2019s disease in cognitively normal older adults","volume":"46","author":"Donovan","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215708_ref11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","article-title":"Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults","volume":"175","author":"Donovan","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-215708_ref12","doi-asserted-by":"crossref","first-page":"e198964","DOI":"10.1001\/jamanetworkopen.2019.8964","article-title":"Longitudinal association of depression symptoms with cognition and cortical amyloid among community-dwelling older adults","volume":"2","author":"Gatchel","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.3233\/JAD-215708_ref13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-191078","article-title":"Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults","volume":"74","author":"Babulal","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215708_ref14","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-215708_ref15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between amyloid imaging load and cerebrospinal fluid A\u03b242 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215708_ref16","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-215708_ref17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jalz.2018.01.013","article-title":"Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging","volume":"14","author":"Schindler","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215708_ref18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer\u2019s disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-215708_ref19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/\u03b2-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-215708_ref20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","article-title":"Differences in the A\u03b240\/A\u03b242 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype","volume":"48","author":"Fagan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215708_ref21","doi-asserted-by":"crossref","first-page":"e051085","DOI":"10.1002\/alz.051085","article-title":"Correspondence of CSF biomarkers measured by Lumipulse assays with amyloid PET","volume":"17","author":"Volluz","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215708_ref22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1037\/1040-3590.7.1.80","article-title":"Short form of the Profile of Mood States (POMS-SF): Psychometric information","volume":"7","author":"Curran","year":"1995","journal-title":"Psychol Assess"},{"key":"10.3233\/JAD-215708_ref23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1532-5415.1990.tb05701.x","article-title":"Relation of cognitive status and abnormal behaviors in Alzheimer\u2019s disease","volume":"38","author":"Cooper","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-215708_ref24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jalz.2018.04.013","article-title":"Biomarkers of agitation and aggression in Alzheimer\u2019sdisease: A systematic review","volume":"14","author":"Ruthirakuhan","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215708_ref25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/gps.2263","article-title":"The impact of anxiety on conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"24","author":"Devier","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S0033291709991577","article-title":"Affective symptoms as predictors of Alzheimer\u2019s disease in subjects with mild cognitive impairment: A 10-year follow-up study","volume":"40","author":"Ramakers","year":"2010","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-215708_ref27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jagp.2016.05.015","article-title":"Anxiety as a predictor for cognitive decline and dementia: A systematic review and meta-analysis","volume":"24","author":"Gulpers","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jagp.2014.10.005","article-title":"Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease","volume":"23","author":"Mah","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF03324782","article-title":"Fatigue in older adults: An early indicator of the aging process?","volume":"22","author":"Avlund","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"10.3233\/JAD-215708_ref30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1041610217001909","article-title":"Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults","volume":"30","author":"Mortby","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-215708_ref31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jagp.2019.01.215","article-title":"Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults","volume":"27","author":"Creese","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215708_ref32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mildbehavioral impairment is associated with \u03b2-amyloid but nottau or neurodegeneration in cognitively intact elderly individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215708_ref33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasmaneurofilament light: A marker of neurodegeneration in mildbehavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215708_ref34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S003329171700126X","article-title":"Cognitive reserve as a moderator of the negative association between mood and cognition: Evidence from a population-representative cohort","volume":"48","author":"Opdebeeck","year":"2018","journal-title":"Psychol Med"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:36Z","timestamp":1777370736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":34,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-215708","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]}}}